Apogee Biotechnology Corporation

Hummelstown, PA

UEI
J9Q4KEGSLWY9
CAGE
46D87
Primary NAICS
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1214 Research Blvd #2014, Hummelstown, PA 17036, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
Modulation of cancer radiotherapy by ABC294640 HHSN261201400016C National Cancer Institute (NIH) $200,000
Drugs and biologicals HHSO100201100029C Office of the Assistant Secretary for Preparedness and Response $2,783,095

Grant awards

Award Agency Obligated Awarded
Opaganib as a medical countermeasure for gastrointestinal acute radiation syndrome R44AI179348 National Institute of Allergy and Infectious Diseases (NIH) $2,587,092
Treatment of neuroblastoma by inhibition of sphingosine kinase R43CA235804 National Cancer Institute (NIH) $225,000
Clinical trial of ABC294640 in patients with refractory multiple myeloma R44CA199767 National Cancer Institute (NIH) $1,979,746
Radiosensitizing prostate cancer by downregulation of androgen receptors and c-MYC R43CA192414 National Institutes of Health $225,000
An early-phase clinical trial evaluating ABC294640 in patients with refractory/RE R42CA183708 National Institutes of Health $1,062,425

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Apogee Biotechnology Corporation registered in SAM.gov?

Yes. Apogee Biotechnology Corporation's SAM.gov registration is active through December 29, 2026.

What is Apogee Biotechnology Corporation's most recent federal award?

Apogee Biotechnology Corporation's most recent federal grant award is Opaganib as a medical countermeasure for gastrointestinal acute radiation syndrome (R44AI179348), from National Institute of Allergy and Infectious Diseases (NIH), on August 1, 2023.

On GovTribe

See Apogee Biotechnology Corporation's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login